HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

S Del Prato Selected Research

Glipizide (Glucotrol)

1/2016Comparison of alogliptin and glipizide for composite endpoint of glycated haemoglobin reduction, no hypoglycaemia and no weight gain in type 2 diabetes mellitus.
6/2015Long-term glycaemic response and tolerability of dapagliflozin versus a sulphonylurea as add-on therapy to metformin in patients with type 2 diabetes: 4-year data.
12/2014Durability of the efficacy and safety of alogliptin compared with glipizide in type 2 diabetes mellitus: a 2-year study.
11/2014Durability of glycaemic efficacy over 2 years with dapagliflozin versus glipizide as add-on therapies in patients whose type 2 diabetes mellitus is inadequately controlled with metformin.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


S Del Prato Research Topics

Disease

45Type 2 Diabetes Mellitus (MODY)
01/2019 - 05/2001
12Insulin Resistance
09/2019 - 01/2000
10Type 1 Diabetes Mellitus (Autoimmune Diabetes)
02/2013 - 06/2000
6Glucose Intolerance
09/2011 - 05/2001
6Metabolic Syndrome (Dysmetabolic Syndrome X)
01/2010 - 01/2000
5Hyperglycemia
10/2016 - 05/2001
4Gestational Diabetes (Gestational Diabetes Mellitus)
09/2019 - 01/2005
4Inflammation (Inflammations)
09/2019 - 06/2004
4Weight Gain
01/2016 - 01/2005
4Diabetes Complications
04/2004 - 05/2001
3Obesity
01/2019 - 01/2000
3Diabetes Mellitus
10/2017 - 09/2002
3Body Weight (Weight, Body)
06/2015 - 01/2005
3Cardiovascular Diseases (Cardiovascular Disease)
05/2009 - 09/2002
2Hypoglycemia (Reactive Hypoglycemia)
01/2019 - 06/2001
2Albuminuria
01/2016 - 02/2004
2Urinary Tract Infections (Urinary Tract Infection)
06/2015 - 11/2014
2Myocardial Infarction
11/2012 - 09/2003
2Stroke (Strokes)
11/2012 - 09/2003
2Prediabetic State (Prediabetes)
05/2009 - 09/2007
2Hypertension (High Blood Pressure)
05/2009 - 08/2003
2Disease Progression
11/2005 - 10/2004
2Proteinuria
03/2005 - 04/2004
2Thrombosis (Thrombus)
03/2005 - 03/2005
2Diabetic Nephropathies (Diabetic Nephropathy)
09/2004 - 04/2003
1Fatigue
01/2019
1Hypersensitivity (Allergy)
01/2019
1Heart Failure
11/2015
1Rare Diseases (Rare Disease)
02/2015
1Neuroendocrine Tumors (Neuroendocrine Tumor)
02/2015
1Pancreatitis
12/2014
1Infections
11/2014
1Sudden Death
11/2012
1Wounds and Injuries (Trauma)
03/2010
1Diabetic Foot
03/2010
1Vascular Diseases (Vascular Disease)
07/2009
1Coronary Disease (Coronary Heart Disease)
05/2009

Drug/Important Bio-Agent (IBA)

34Glucose (Dextrose)FDA LinkGeneric
01/2019 - 01/2000
21Insulin (Novolin)FDA Link
01/2019 - 01/2000
11Metformin (Glucophage)FDA LinkGeneric
01/2019 - 09/2003
5VildagliptinIBA
01/2019 - 08/2007
5LinagliptinIBA
10/2016 - 03/2011
4Glipizide (Glucotrol)FDA LinkGeneric
01/2016 - 11/2014
4Insulin Glargine (Lantus)FDA Link
02/2015 - 03/2008
4Pharmaceutical PreparationsIBA
10/2014 - 04/2004
4Hypoglycemic Agents (Hypoglycemics)IBA
08/2013 - 10/2004
3dapagliflozinIBA
07/2017 - 11/2014
3LipidsIBA
06/2016 - 01/2000
3insulin degludecIBA
02/2015 - 02/2013
3HDL CholesterolIBA
05/2009 - 03/2005
3Triglycerides (Triacylglycerol)IBA
05/2009 - 01/2000
3Dipeptidyl Peptidase 4 (Dipeptidyl Peptidase IV)IBA
06/2008 - 07/2007
2SodiumIBA
07/2017 - 02/2004
2CarbohydratesIBA
06/2016 - 03/2003
2alogliptinIBA
01/2016 - 12/2014
2Glucagon-Like Peptide 1 (GLP 1)IBA
10/2011 - 06/2008
2Fatty Acids (Saturated Fatty Acids)IBA
01/2010 - 01/2000
2Blood Glucose (Blood Sugar)IBA
10/2009 - 09/2003
2Insulin Lispro (Humalog)FDA Link
10/2009 - 06/2001
2Proteins (Proteins, Gene)FDA Link
04/2008 - 08/2003
2Glucagon (Glukagon)FDA Link
07/2007 - 11/2004
2Heparin (Liquaemin)FDA LinkGeneric
03/2005 - 03/2005
2Nonesterified Fatty Acids (NEFA)IBA
09/2003 - 01/2000
2Fibrinogen (Factor I)FDA Link
09/2003 - 08/2003
1ApelinIBA
09/2019
1LeptinIBA
09/2019
1Fatty Acid-Binding ProteinsIBA
09/2019
1AdiponectinIBA
09/2019
1ResistinIBA
09/2019
1AdipokinesIBA
09/2019
1Nicotinamide PhosphoribosyltransferaseIBA
09/2019
1alirocumabIBA
10/2017
1Sodium-Glucose Transporter 2 InhibitorsIBA
07/2017
1Glycated Hemoglobin (Glycosylated Hemoglobin)IBA
10/2016
1Dietary Fats (Dietary Fat)IBA
06/2016
1Glucagon-Like Peptide-1 ReceptorIBA
01/2016
1dulaglutideIBA
01/2016
1MineralsIBA
02/2015
1glimepiride (Amarel)FDA LinkGeneric
05/2014
1Sitagliptin Phosphate (Januvia)FDA Link
08/2013
1C-PeptideIBA
06/2013
1AntibodiesIBA
02/2013
1FrataxinIBA
06/2012
1CholesterolIBA
09/2011
1dermacynIBA
03/2010
1SolutionsIBA
03/2010
1Local Anti-Infective Agents (Antiseptics)IBA
03/2010
1Hydrochlorothiazide (Esidrix)FDA LinkGeneric
01/2010
1IrbesartanFDA LinkGeneric
01/2010
1Angiotensin Receptor AntagonistsIBA
01/2010
1G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA
01/2010
1Isophane Insulin (NPH Insulin)FDA Link
10/2009
1perindopril drug combination indapamideIBA
07/2009
1Gliclazide (Diamicron)IBA
07/2009
1HDL LipoproteinsIBA
05/2009
1Exenatide (Byetta)FDA Link
06/2008

Therapy/Procedure

16Therapeutics
06/2015 - 05/2001
4Transplantation
07/2010 - 08/2003
2Glycemic Control
12/2003 - 06/2001
1Surgical Amputation (Amputations)
11/2012